Brook Byers
Partner, Kleiner Perkins Caufield & Byers
Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than forty new technology based ventures, over half of which have already become public companies. Brook was the founding president and chairman of four biotechnology companies, incubated in KPCB's offices, that went on to become public companies with an aggregate market value of more than $8 billion. He is currently on the board of directors of seven companies, most recently joining Genomic Health Incorporated and Five Prime Therapeutics.
Brook was president and a director of the Western Association of Venture Capitalists and is a contributing author to the book “Guide to Venture Capital.” He is currently a board member of the University of California at San Francisco Medical Foundation, the California Healthcare Institute and the Stanford Eye Council. He was formerly a Director of the Entrepreneurs Foundation, the Asian Art Museum in San Francisco, the Stanford Graduate School of Business Advisory Council, That Man May See (UCSF) Vision Research Foundation (Chairman) and the Georgia Tech Advisory Board. Raised in Atlanta, Georgia, Brook graduated in Electrical Engineering from Georgia Tech and received an MBA from Stanford.